Cell Therapy for Brain Injury
Editat de David C. Hessen Limba Engleză Hardback – iun 2015
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 921.39 lei 6-8 săpt. | |
Springer International Publishing – 17 oct 2016 | 921.39 lei 6-8 săpt. | |
Hardback (1) | 927.37 lei 6-8 săpt. | |
Springer International Publishing – iun 2015 | 927.37 lei 6-8 săpt. |
Preț: 927.37 lei
Preț vechi: 1130.93 lei
-18% Nou
Puncte Express: 1391
Preț estimativ în valută:
177.47€ • 186.66$ • 147.83£
177.47€ • 186.66$ • 147.83£
Carte tipărită la comandă
Livrare economică 03-17 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783319150628
ISBN-10: 3319150626
Pagini: 521
Ilustrații: XI, 369 p. 41 illus., 35 illus. in color.
Dimensiuni: 155 x 235 x 27 mm
Greutate: 0.71 kg
Ediția:2015
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3319150626
Pagini: 521
Ilustrații: XI, 369 p. 41 illus., 35 illus. in color.
Dimensiuni: 155 x 235 x 27 mm
Greutate: 0.71 kg
Ediția:2015
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Public țintă
ResearchCuprins
Introduction to Cell Therapy in Brain Injury.- Cell Based Therapeutics in Stroke: An Industry Perspective.- Autologous Mesenchymal Stem Cell Therapy in Patients with Stroke.- Treatment of Autologous Bone Marrow Mononuclear Cells for Acute and Subacute Stroke: Cell-Therapy for Acute/Subacute Stroke.- Clinical Development of MultiStem® for Treatment of Injuries and Diseases of the Central Nervous System.- Intra-Arterial Approaches to Stem Cell Therapy for Ischemic Stroke.- Neural Stem Cells in Stroke: Intracerebral Approaches.- The CTX Human Neural Stem Cell Line and the PISCES Stroke Trial.- Induced Pluripotent Stem Cells as a Cell-based Therapeutic in Stroke.- Induced Pluripotent Stem Cell Derived Neural Cell Types In Treatment of Stroke.- Preconditioning and Cell-based Therapeutics.- Tracking of Administered Progenitor Cells in Brain Injury and Stroke by Magnetic Resonance Imaging.- Biomaterials Application in Stem Cell Therapies for Stroke.- A Stem Cell Derived Cell-Free Therapy for Stroke: Moving Conditioned Medium into Clinical Trial.- Pathophysiology of Traumatic Brain Injury: Rationale and Role for Cellular Therapies.- Stem Cell Therapy for Neonatal Hypoxic-Ischemic Brain Injury.- Cell-Based Therapies in Neonatal Stroke.- Issues in Clinical Trial Design in Stem Cell Trials after Stroke.
Notă biografică
Dr. David C. Hess, MD is currently Chairman and Professor, Department of Neurology, Joint Appointment, Institute of Molecular Medicine and Genetics and Joint Appointment, College of Graduate Studies at Georgia Regents University. He completed his MD at University of Maryland Medical College of Georgia in Baltimore and an internship and residency in Internal Medicine at Allegheny General Hospital in Pittsburgh, before completing an additional residency in Neurology at Georgia Health Sciences University in Augusta. Dr. Hess has authored or co-authored more than 150 papers. This book reflects the intersection between Dr. Hess' clinical interest in stroke and his research interest in stem cells.
Textul de pe ultima copertă
This is a review of state-of-the-art cell therapy in the treatment of stroke, traumatic brain injuries and neonatal stroke and hypoxia-ischemia using a variety of cells ranging from bone marrow derived stem cells and mesenchymal stem cells to induced pluripotent stem cells derived neural progenitors. This invaluable book covers this niche topic in depth from basic stem cell biology and principles of cell therapy through proposed mechanisms of action of cell therapy in stroke, pre-clinical data in stroke models, ongoing clinical trials, imaging and tracking of cells with MRI, neural stem cells in stroke, approaches using conditioned medium, and the "big pharma" perspective of cell therapy. Each of eighteen chapters has been contributed by a well-known leader in each field, thus providing a wealth of international perspective and expertise. Cell Therapy for Brain Injury’s breadth makes it essential reading for neuroscientists, stem cell biologists, researchers or clinical trialists at pharmaceutical or biotechnology companies. It also serves as a thorough introduction for graduate students or post-doctoral fellows who hope to work in these fields.
Caracteristici
Covers basic stem cell biology and principles of cell therapy Includes expertise on key topics like pros and cons of the use of conditioned media instead of cells, methods to enhance the potency of cells in host tissue and the in vivo tracking of cells/stem cells in the brain Reaches into the corporate sector with coverage of cell therapy from the perspective of biotech and "big Pharma" companies Includes supplementary material: sn.pub/extras